Patents Assigned to Cilian AG
  • Patent number: 11584920
    Abstract: Disclosed is a combination of two or more lipase enzymes, and its use for treating a lipid digestion deficiency and/or a digestive disorder. At least one lipase enzyme has a pH optimum at an acidic pH value, while at least one other lipase enzyme has a pH optimum at an alkalic pH value.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: February 21, 2023
    Assignee: CILIAN AG
    Inventors: Marcus Wolf William Hartmann, Ingo Aldag
  • Patent number: 10590402
    Abstract: Disclosed is a combination of two or more lipase enzymes, and its use for treating a lipid digestion deficiency and/or a digestive disorder. At least one lipase enzyme has a pH optimum at an acidic pH value, while at least one other lipase enzyme has a pH optimum at an alkalic pH value.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: March 17, 2020
    Assignee: CILIAN AG
    Inventors: Marcus Wolf William Hartmann, Ingo Aldag
  • Publication number: 20200071683
    Abstract: Disclosed is a combination of two or more lipase enzymes, and its use for treating a lipid digestion deficiency and/or a digestive disorder. At least one lipase enzyme has a pH optimum at an acidic pH value, while at least one other lipase enzyme has a pH optimum at an alkalic pH value.
    Type: Application
    Filed: November 18, 2019
    Publication date: March 5, 2020
    Applicant: CILIAN AG
    Inventors: Marcus Wolf William Hartmann, Ingo Aldag
  • Patent number: 9963499
    Abstract: The present invention is related to a system for the heterologous expression of a monoclonal Antibody (mAb) or a fragment or derivative thereof, said system comprising at least one ciliate host cell, and incorporated, into said ciliate host cell, at least one heterologous nucleic acid molecule encoding for said monoclonal Antibody, or a fragment or derivative thereof.
    Type: Grant
    Filed: March 2, 2011
    Date of Patent: May 8, 2018
    Assignee: CILIAN AG
    Inventors: Marcus Hartmann, Jenny Apelt
  • Publication number: 20130109593
    Abstract: The present invention is related to a system for the heterologous expression of a monoclonal Antibody (mAb) or a fragment or derivative thereof, said system comprising at least one ciliate host cell, and incorporated, into said ciliate host cell, at least one heterologous nucleic acid molecule encoding for said monoclonal Antibody, or a fragment or derivative thereof.
    Type: Application
    Filed: March 2, 2011
    Publication date: May 2, 2013
    Applicant: CILIAN AG
    Inventors: Marcus Hartmann, Jenny Apelt
  • Patent number: 8309321
    Abstract: A method for identifying a protease secretion deficient strain of a microorganism involves producing a mutant of the microorganism, followed by adding the mutant to gel-filled wells of a microtitration plate, incubating the mutant in the gel-filled wells under conditions call sing the mutant to secrete proteins, separating the mutant from the gel, and measuring activity of a secretion protease of the microorganism in the gel, wherein either (i) the gel is a substrate for the secretion protease or (ii) the gel contains a substrate for the secretion protease.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: November 13, 2012
    Assignee: Cilian AG
    Inventors: Marcus Hartmann, Andre Broermann
  • Patent number: 8114650
    Abstract: A method for producing a ciliate cell with reduced or essentially no dihydrofolate reductase (DHFS) activity or reduced or essentially no thymidylate synthase (TS) activity or both reduced or essentially no dihydrofolate reductase and thymidylate synthase (DHFR-TS) activity is claimed, comprising the steps of a) transforming ciliate cells by inserting a construct containing an allele altering the gene encoding the endogenous DHFR-TS into at least one of the endogenous DHFR-TS genes of the ciliate macronucleus (MAC), b) inducing an allelic assortment process in the transformed ciliate cells to generate cells having the construct inserted in most or all functional DHFR-TS genes of the MAC, and c) identifying the cells generated in step b) by cultivation with or without thymidine.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: February 14, 2012
    Assignee: Cilian AG
    Inventors: Thomas Weide, Ulrike Bockau, Marcus Hartmann, Lutz Herrmann
  • Patent number: 7723506
    Abstract: A method characterizes samples having units by monitoring fluctuating intensities of radiation emitted, scattered, and/or reflected by the units in at least one measurement volume, the monitoring being performed by at least one detection device, the method comprising the steps of: a) measuring in a repetitive mode a number of photon counts per time interval of defined length, b) determining a function of the number of photon counts per the time interval, and c) determining a function of specific brightness of the units on basis of the function of the number of photon counts.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: May 25, 2010
    Assignee: Cilian AG
    Inventors: Marcus Hartmann, Thomas Weide, Lutz Herrmann, Nadine Niebur
  • Patent number: 7045330
    Abstract: A nucleic acid coding for the phospholipase A1 from ciliates. In particular, the phospholipase A1 has the amino acid sequence SEQ ID No. 7.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: May 16, 2006
    Assignee: Cilian AG
    Inventors: Marcus Hartmann, Marco Grenningloh, Arno Tiedtke